ALS/FTD
Showing 1 - 25 of 751
Amyotrophic Lateral Sclerosis Trial in Jacksonville
Recruiting
- Amyotrophic Lateral Sclerosis
-
Jacksonville, FloridaMayo Clinic in Florida
Nov 9, 2022
Amyotrophic Lateral Sclerosis, Frontotemporal Dementia Trial in Worldwide (TPN-101, 400 mg/day, Placebo)
Recruiting
- Amyotrophic Lateral Sclerosis
- Frontotemporal Dementia
- TPN-101, 400 mg/day
- Placebo
-
Orange, California
- +4 more
Mar 9, 2022
ALS, FTD Trial in Utrecht (WVE-004)
Enrolling by invitation
- ALS
- FTD
-
Utrecht, NetherlandsUniversitair Medisch Centrum Utrecht
Jan 4, 2023
ALS, FTD Trial in Worldwide (WVE-004, Placebo)
Active, not recruiting
- ALS
- FTD
- WVE-004
- Placebo
-
North Ryde, New South Wales, Australia
- +16 more
Feb 2, 2023
C9orf72 Amyotrophic Lateral Sclerosis (ALS), Frontotemporal Dementia Trial in Gainesville (Metformin)
Recruiting
- C9orf72 Amyotrophic Lateral Sclerosis (ALS)
- Frontotemporal Dementia
-
Gainesville, FloridaUF Health at the University of Florida
Sep 7, 2021
Research Repository on Neurodegenerative Disease
Recruiting
- Frontotemporal Degeneration(FTD)
- +8 more
- No intervention
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Jul 9, 2022
EEG and TMS-based Biomarkers of ALS, MS and FTD
Recruiting
- Amyotrophic Lateral Sclerosis
- +2 more
- 128 electrode electroencephalography (EEG)
- Transcranial magnetic stimulation (TMS)
-
Dublin, Leinster, IrelandAcademic Unit of Neurology, Trinity College Dublin, The Universi
Jun 2, 2021
Frontotemporal Lobar Degeneration (ARTFL)
Completed
- FTLD
- +11 more
-
Birmingham, Alabama
- +16 more
May 18, 2021
Relatives, Health Care Providers, Cognitive Impairment Trial in Aarhus (EMBRACE (relatives), EMBRACE (Health care providers))
Active, not recruiting
- Relatives
- +3 more
- EMBRACE (relatives)
- EMBRACE (Health care providers)
-
Aarhus, DenmarkThe Danish national Rehabilitation Center for neuromuscular dise
Nov 16, 2020
Amyotrophic Lateral Sclerosis Trial in Worldwide (Lithium Carbonate 400 MG)
Recruiting
- Amyotrophic Lateral Sclerosis
- Lithium Carbonate 400 MG
-
Adelaide, Australia
- +12 more
Aug 21, 2023
Phenotype, Genotype and Biomarkers 2
Recruiting
- Amyotrophic Lateral Sclerosis
- +4 more
-
Miami, Florida
- +3 more
Dec 19, 2022
Novel MRI Biomarkers for Monitoring Disease Progression in ALS
Recruiting
- Amyotrophic Lateral Sclerosis
- Motor Neuron Disease
-
Miami, Florida
- +8 more
Jan 24, 2023
The Pre-symptomatic Familial Amyotrophic Lateral Sclerosis Study
Recruiting
- Amyotrophic Lateral Sclerosis
-
Miami, FloridaUniversity of Miami
Apr 5, 2022
Amyotrophic Lateral Sclerosis (ALS) Families Project
Recruiting
- ALS
-
New York, New YorkColumbia University
Oct 20, 2021
Genetic Frontotemporal Dementia Initiative for Neurodevelopment
Recruiting
- Frontotemporal Dementia
- Family Members
-
London, Ontario, CanadaWestern University
Mar 23, 2023
Familial and Sporadic ALS/Motor Neuron Disease, Miyoshi Myopathy
Enrolling by invitation
- Amyotrophic Lateral Sclerosis
- +9 more
-
Worcester, MassachusettsUniversity of Massachusetts Medical School
May 16, 2022
Amyotrophic Lateral Sclerosis, Frontal Temporal Dementia Trial in United States (Memantine, Placebo (for Memantine))
Completed
- Amyotrophic Lateral Sclerosis
- Frontal Temporal Dementia
- Memantine
- Placebo (for Memantine)
-
Phoenix, Arizona
- +12 more
Nov 8, 2022
Amyotrophic Lateral Sclerosis Trial (Neuroimaging and electrophysiology)
Not yet recruiting
- Amyotrophic Lateral Sclerosis
- Neuroimaging and electrophysiology
- (no location specified)
May 2, 2022
ALSFTD Trial in Montréal (Probiotic, Placebo)
Not yet recruiting
- ALSFTD
- Probiotic
- Placebo
-
Montréal, Quebec, CanadaCentre Hospitalier de l'Université de Montréal
Sep 18, 2023
Amyotrophic Lateral Sclerosis Trial in France (Deferiprone, Placebo Oral Tablet)
Active, not recruiting
- Amyotrophic Lateral Sclerosis
- Deferiprone
- Placebo Oral Tablet
-
Angers, France
- +14 more
Nov 4, 2022
Olfactory Deficits in Neurologic Disease
Completed
- Alzheimer Disease
- +5 more
-
Boston, MassachusettsMassachusetts General Hospital
Aug 18, 2021
Neurodegenerative Disease Trial in Philadelphia ([18F]T807)
Recruiting
- Neurodegenerative Disease
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Mar 24, 2022
Amyotrophic Lateral Sclerosis Trial (Standard care)
Not yet recruiting
- Amyotrophic Lateral Sclerosis
- Standard care
- (no location specified)
Aug 27, 2021
Amyotrophic Lateral Sclerosis, Alzheimer, Mild Cognitive Impairment Trial in Fort Lauderdale, Boston (Baricitinib)
Not yet recruiting
- Amyotrophic Lateral Sclerosis
- +2 more
-
Fort Lauderdale, Florida
- +1 more
Jan 25, 2022